Viewing StudyNCT00053092



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00053092
Status: COMPLETED
Last Update Posted: 2013-12-18
First Post: 2003-01-27

Brief Title: Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
Sponsor: Institute of Cancer Research United Kingdom
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000269136
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Institute of Cancer Research United Kingdom
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Australasian Leukaemia and Lymphoma Group OTHER